BioCentury
ARTICLE | Company News

GENZ gets Fabrazyme FDA response

October 22, 2001 7:00 AM UTC

Genzyme (GENZ) received a second response letter from the FDA for its BLA for Fabrazyme agalsidase beta to treat Fabry disease. GENZ said the letter specifies additional data and information the FDA i...